Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05111548 · ClinicalTrials.gov registry record · NA

Brain Stimulation and Cognitive Training - Efficacy

A NA study of Schizophrenia and Bipolar Disorder, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT05111548 is a NA study of Schizophrenia and Bipolar Disorder that has completed, run by University of Michigan. The registered enrollment target is 19 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05111548, a NA study of Schizophrenia and Bipolar Disorder, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

People with serious mental illness often experience difficulties with thinking skills like memory. These difficulties can make it harder to perform day-to-day activities. The purpose of this study is to test whether combining a type of non-invasive brain stimulation with computerized cognitive exercises is helpful in improving a specific type of memory skill in people who have mental health conditions. The study is a randomized clinical trial, meaning that participants will be randomly assigned to receive either 'active' or 'inactive' brain stimulation. All participants will complete computerized cognitive exercises, also known as cognitive training. Overall, participants will be in the study for 6-8 weeks. The study involves 10 visits to the clinic over 2-4 weeks for cognitive training and either active or inactive brain stimulation. Participants will also complete paper-and-pencil assessments at the beginning and end of treatment, and one month after treatment ends.

Interventions

  • DEVICE tDCS (Active)
  • BEHAVIORAL BrainHQ
  • DEVICE tDCS (Inactive)

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2021-09-08
Est. Completion 2023-05-12
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05111548

The ClinicalTrials.gov registry entry for NCT05111548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (91% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Schizophrenia appearing as the primary indexed condition, and to 3 interventions - of which tDCS (Active) is the first listed.

NCT05111548 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05111548 about?

NCT05111548 is a clinical study titled "Brain Stimulation and Cognitive Training - Efficacy". People with serious mental illness often experience difficulties with thinking skills like memory. These difficulties can make it harder to perform day-to-day activities. The purpose of this study is to test whether combining a type of non-invasive brain stimulation with computerized cognitive exerc...

What is the current status of trial NCT05111548?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2021-09-08. Estimated completion is 2023-05-12.

What conditions does trial NCT05111548 study?

This clinical trial studies the following conditions: Schizophrenia, Bipolar Disorder, Schizo Affective Disorder.

What interventions are being tested in trial NCT05111548?

The interventions under investigation include: tDCS (Active) (DEVICE), BrainHQ (BEHAVIORAL), tDCS (Inactive) (DEVICE).

Who is sponsoring clinical trial NCT05111548?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05111548 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.